SCHEMBL16765776

SCHEMBL16765776

O=CN1CCOC(c2ccc(-c3ccc(Br)cc3)o2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.39
KDM4E B2RXH2 7/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
GAA P10253 2/20 0.39
HSP90AA1 P07900 1/20 0.39
ALOX12 P18054 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
PKM P14618 2/20 0.38
ALDH1A1 P00352 8/20 0.36
PDE4B Q07343 2/20 0.35
HSD17B10 Q99714 3/20 0.34
LMNA P02545 3/20 0.34
HPGD P15428 2/20 0.34
PRNP P04156 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 3/20 0.33
MAPK1 P28482 3/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3120324 0.78 NPC1 (0.36) SMN1; SMN2GAANPC1RAB9AALDH1A1
SCHEMBL19253755 0.69 CTSL (0.37) KDM4EHTTALDH1A1HPGDPOLB
SCHEMBL28449775 0.69 CHRM2 (0.39) MAPTKDM4ESMN1; SMN2GAAHTT
SCHEMBL3120308 0.69 CTSL (0.43)
SCHEMBL295269 0.68 CNR2 (0.46) TSHRMEN1KMT2A
SCHEMBL1633511 0.67 DRD3 (0.36) PDE4BMEN1KMT2A
SCHEMBL11633671 0.65 ALDH1A1 (0.41) MAPTKDM4ESMN1; SMN2GAAHSP90AA1
SCHEMBL2184010 0.65 CTSL (0.33)
SCHEMBL5055418 0.63 AR (0.38)
SCHEMBL31206798 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250099539-A1 METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS MASSACHUSETTS EYE AND EAR INFIRMARY 2025-03-27 US disclosed
US-9433610-B2 Compounds that enhance Atoh1 expression MASSACHUSETTS EYE & EAR INFIRMARY (US) 2016-09-06 US disclosed
US-20150157607-A1 Compounds that Enhance Atoh1 Expression MASSACHUSETTS EYE & EAR INFIRMARY 2015-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250099539-A1 METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS HES1, NOTCH1, NOTCH4 MAPT 3747/4885KDM4E 3697/4885SMN1; SMN2 4643/4885
US-20150157607-A1 Compounds that Enhance Atoh1 Expression DACH1, EZH1, CREBBP MAPT 3010/4885KDM4E 1336/4885SMN1; SMN2 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.